Table 2 Use of VL Testing by Calendar Year from 2010 to 2017 (n = 66,042 patients) a
2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Total # of tests | 11 | 9 | 84 | 970 | 826 | 864 | 17,549 | 20,221 |
# and % of unsuppressed tests | 7 (63.6%) | 4 (44.4%) | 15 (17.9%) | 408 (42.1%) | 428 (51.8%) | 306 (35.4%) | 6988 (39.8%) | 10,790 (53.4%) |
Total # of patients active on ART | 3913 | 8943 | 16,003 | 24,099 | 31,078 | 35,772 | 43,229 | 39,469 |
# and % of patients with at least 1 test | 11 (0.3%) | 9 (0.1%) | 64 (0.4%) | 951 (3.9%) | 786 (2.5%) | 839 (2.3%) | 16,392 (37.9%) | 18,828 (47.7%) |
# and % of suppressed patients among patients with at least 1 test | 4 (36.4%) | 5 (55.6%) | 51 (79.7%) | 547 (57.5%) | 378 (48.1%) | 544 (64.8%) | 9864 (60.2%) | 8968 (47.6%) |